Pseudomyxoma Peritonei

Authors

  • Luciana Sousa Serviço de Medicina interna, Serviço de Cirurgia Geral, Hospital de Braga, Portugal
  • Margarida Fonseca Serviço de Medicina interna, Serviço de Cirurgia Geral, Hospital de Braga, Portugal
  • Rita Magalhães Serviço de Medicina interna, Serviço de Cirurgia Geral, Hospital de Braga, Portugal
  • Sofia Caridade Serviço de Medicina interna, Serviço de Cirurgia Geral, Hospital de Braga, Portugal
  • Pedro Leão Serviço de Medicina interna, Serviço de Cirurgia Geral, Hospital de Braga, Portugal
  • Humberto Cristino Serviço de Medicina interna, Serviço de Cirurgia Geral, Hospital de Braga, Portugal
  • Ilídio Brandão Serviço de Medicina interna, Serviço de Cirurgia Geral, Hospital de Braga, Portugal

DOI:

https://doi.org/10.24950/rspmi.902

Keywords:

Pseudomyxoma Peritonei, Adenocarcinoma, Mucinous, Mucins

Abstract

Pseudomyxoma peritonei (PMP) is a disease characterized
by production and accumulation of a mucinous fluid in the
peritoneal cavity, resulting in most cases from mucin producing tumors generally of the appendix and ovaries but
less frequently from the pancreas, colon and bladder. It is
a rare disease, more frequent in women, with an estimated
incidence of one case per million per year, with a mean age
of 50-70 years. Clinically it has a painless indolent course
and consequently diagnosis is made at an advanced stage.
Treatment consists in peritonectomy and visceral resections, called cytoreductive surgery (CRS), in combination
with hyperthermic intraperitoneal chemotherapy. In this
article we report the case of an elderly patient with pseudomyxoma peritonei with probable origin in the left ovar

Downloads

Download data is not yet available.

References

Bochi C, Buhler R, Buhler JÁ. Pseudomixoma peritonei: relato de caso e revisão da literatura. Scientia Med. 2007;1):36-9.

Lee NK, Kim HS, Jeon TY, Kim GH, Kim DU, Park DY, et al. Spectrum of mucin-producing neoplastica conditions of the abdomen

and pelvis:cross-sectional imaging evaluation. Word J Gastroenterol 2011;17:4757-71.

Zhi-Bo Qu, Lian-Xin Liu. Management of pseudomyxoma peritonei. World J Gastroenterol. 2006;12:6124-7.

Sree HT, Margaret FH, Rebecca A, Wael S, Cynthia W, Frank L, et al.

Mucinous neoplasms of the appendix: a current comprehensive clinicopathologic and imaging review. Cancer Imaging. 2013;13:1425.

Connor SJ, Hanna GB, Frizelle FA. Appendiceal tumors: Retrospective

clinicopathologic analysis of appendiceal tumors from 7,970 appendectomies.Dis Colon Rectum. 1998;41:75-80.

Touloumis Z, Galyfos G, Kavouras N, Menis M, Lavant L. Aggressive Pseudomyxoma Peritonei: A Case Report with an Unusual Clinical Presentation. Case Rep Oncol Med. 2013;2013:926963.

Agrawal AK, Bobiński P, Grzebieniak D, Rudnicki J, Marek G, Kobielak P,

Kazanowski M, Agrawal S, Hałoń A. Pseudomyxoma peritonei originating from urachus— case report and review of the literature. Curr Oncol.

Fev 21(1):155-165.

Saad-Hossne R, Prado RG, Bakonyi Neto A, Marchezan MA. Peritoneal

pseudomyxoma associated with synchronic malignant mucinous neoplasias of the cecum, appendix and rectum. Case report and review of

the literature. Acta Cir Bras. 2007;22:407-11.

Mohtaram A, Boutayeb S, El Youbi MB, Sghiri T, Aaribi I, Kettani F, et al. Pseudomyxome péritonéale résultant d’un tératome ovarien associé

à une tumeur mucineuse bordeline: à propos d’un cas et revue de la littérature. Pan Afr Med J. 2013;14:156.

Hart WR. Borderline epithelial tumors of the ovary. Mod Pathol. 2005;18 Suppl 2:S33-50.

Oliveira AM, Rodrigues CG, Borges A, Martins A, Loureiro dos Santos S, Pires FR,et al. Pseudomyxoma peritonei: a clinical case of this poorly understood condition. IInt J Gen Med. 2014;7:137-41.

Min HS, Hui Pyo J, Moon ES, Choi J, Kang YS, Lee MJ, et al. Pseudomyxoma Peritonei: A Rare Cause of Oliguric Acute Kidney Injury.

Chonnam Med J. 2013;49:87-90.

Amini A, Masoumi-Moghaddam S, Ehteda A, Morris DL. Secreted mucins in pseudomyxoma peritonei: pathophysiological significance and

potential therapeutic prospects. Orphanet J Rare Dis. 2014;9:71.

Engelen MJ, de Bruijn HW, Hollema H, ten Hoor KA, Willemse PH, Aalders JG, et al. Serum CA 125, carcinoembryonic antigen, and CA19-

as tumor markers in borderline ovarian tumors. Gynecol Oncol. 2000;78:16-20.

Antonopoulosa P, Leonardoua P, Barbagiannisa N, Alexioub K, Demonakouc M, Economoub N. Gastrointestinal and Extragastrointestinal

Stromal Tumors: Report of Two Cases and Review of the Literature.

Case. Rep Gastroenterol 2014(8):61-66.

Additional Files

Published

2015-06-30

How to Cite

1.
Sousa L, Fonseca M, Magalhães R, Caridade S, Leão P, Cristino H, Brandão I. Pseudomyxoma Peritonei. RPMI [Internet]. 2015 Jun. 30 [cited 2024 Nov. 5];22(2):91-3. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/902

Issue

Section

Case Reports

Most read articles by the same author(s)